Newsletters

  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
All
  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
JobsWHO

WHO consultancy: Create online e-learning on antimicrobial stewardship

Dear All, WHO today published a Request for Proposals (RFP) for a consultant to develop an online e-learning course on ...
Read More >
R&D Insight

COVID-19 Insights from Carr, Gottlieb, McClellan / Global AMR R&D Hub Dynamic Dashboard

Dear All, Three things to share this afternoon. First, Alan Carr has published a newsletter (link) reporting the results from ...
Read More >
Government ActionPush/Pull

UK Antibiotic Subscription Pilot implies Pull Incentive of up to $4b across the G20

Note that there is a follow-up newsletter that covers a post-webinar FAQ. After reading this newsletter as introduction, please go ...
Read More >
Can you help?R&D Insight

Let’s help Alan Carr do a COVID-19 point insight survey

Dear All, I promise that the next email will be all about the 25 Mar 2020 NHS England webinar on ...
Read More >
R&D Insight

Send a note to your congressman/woman today!

Dear All, If you are a US citizen, you have an opportunity right now (as in today/tomorrow) to push for ...
Read More >
R&D Insight

Tetraphase sold for $14m … and $600m goes up in smoke!

Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter): Wonkish and long note alert … top-up your coffee ...
Read More >
R&D Insight

Sweden to test an access-focused model for new antibiotics: Contracting for Availability

Dear All: Sweden has been a steady supporter of work on incentives for antibiotics for over a decade – as ...
Read More >
Government ActionR&D Insight

NHS England antibiotic procurement pilot project: Update webinar on 25 Mar 2020

Dear All, This email was just today received from the team leading the NHS England antibiotic procurement project (go here ...
Read More >
JobsWHO

WHO R&D-focused consultancy: Data coordinator for next WHO pipeline review

Dear All, As you know, WHO has been driving a series of clinical and preclinical pipeline reviews (go here for ...
Read More >
FDAMeetings

FDA Workshop: Animal Models To Support Antibacterial Development (5 Mar 2020, post-meeting notes)

Dear All (detailed and wonkish note alert … lots of thinking out loud … get some coffee and settle in!), ...
Read More >
R&D InsightSummaries

What does an antibiotic cost to develop? What is it worth? How to afford it?

Dear All (long, wonkish note alert!): Today we have a 3-part discussion of cost and value with this summary 3-part ...
Read More >
R&D Insight

Glaxo seeks buyer for two of its older antibiotics / AMR podcasts to share

Heads-up … numerous changes in the meeting calendar: Lots of new events as well as rescheduling of previously announced events. ...
Read More >
JobsWHO

Consultancy at WHO: manage a fund for implementation of AMR-focused actions / 17 Mar 2020 deadline

Dear All, A fascinating job posting has gone up from WHO and the full text is just below my signature. ...
Read More >
R&D InsightSummaries

Chemicals vs. drugs (Part 3): XKCD has the final word

This newsletter is part of a series — here are the links to Part 1, Part 2, and Part 4. Dear All, ...
Read More >
JobsWHO

WHO consultancy to support AMR-related messaging / 2 Mar 2020 deadline!

Dear All, WHO has just posted a job opening for a consultant in Geneva to help with spreading the word ...
Read More >
R&D InsightSummaries

Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin

This newsletter is part of a series — here are the links to Part 1, Part 3, and Part 4. Dear All ...
Read More >
R&D InsightSummaries

Chemicals vs. drugs (Part 1): The end of bacitracin / the buzz around halicin

This newsletter is the first of a series — here are the links to Part 2, Part 3, and Part ...
Read More >
PK & PK-PDR&D Insight

Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR

Note: See also these related newsletters: 13 Jan 2019 (link) on DTR as part of the language of resistance and ...
Read More >
R&D InsightWonkish

Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?

Dear All (wonk-ish note alert and also with particular thanks as always to Kevin Outterson for helping to refine this ...
Read More >
FDAMeetings

FDA workshop: Animal models to support antibacterial development (5 Mar 2020)

Dear All (moderately long note alert; be sure to note the new list of funding opportunities just below my signature), ...
Read More >
Scroll to Top